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Abstract
Background and Objectives—Laser-activated photodynamic biologic tissue glues may be
useful for closing incisions in ophthalmology. We report on the use of two such preparations to
close perforating corneal incisions in living rats.
Study Design/Materials and Methods—A previously described preparation containing a
covalent albumin-chlorin e6 (ce6) conjugate (bovine serum albumin (BSA)–ce6), and a novel
mixture of albumin and Janus Green (BSA/JG), both activated with a 665-nm diode laser were
used to glue mouse skin ex vivo. The optimized glues were then used to seal incisions in rat
corneas and results were compared to control incisions. Rats were sacrificed at day 1, 7, and 14
and eyes tested for leaking pressure and examined histopathologically.
Results—One day after treatment eyes closed with BSA–ce6 had a leaking pressure (in mmHg)
of 357 compared to 193 for control incisions (P<0.01); closure with BSA/JG gave a leaking
pressure of 430 (P<0.05 compared to BSA–ce6, and P<0.001 compared to control). Histological
examination showed eyes sealed with BSA/JG have less inflammation present than untreated eyes
at 7 days.
Conclusions—These data demonstrate that photodynamic laser activated tissue glues can be
used to effectively seal corneal incisions in living animals without thermal damage or undue
inflammation.
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INTRODUCTION
Closing, sealing, and bonding wounds and defects in tissues remain problem areas in
medicine. Alternative methods to the traditional mechanical means designed to close
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incisions, wounds, and anastomoses have received attention in the last several years. While
sutures and surgical staples remain the gold standard of closure techniques, there are many
situations where they have major disadvantages. Sutures are labor intensive (especially
laparoscopically and in microsurgery), and can lead to infection, and scarring. Particularly
for closure of delicate tissues, such as ophthalmic wounds, primary closure with sutures can
lead to unavoidable issues with tissue warping that can have deleterious effects on vision.
Staples are much less labor-intensive than sutures but can lead to scarring and uneven
healing. Neither of these techniques can easily close a defect in which the edges cannot be
evenly opposed or where the tissues are extremely sensitive such as the eyes. Therefore
much work has gone into the discovery of novel tissue sealants, adhesives, and glues [1].
These alternatives can be divided into four classes.
Firstly, cyanoacrylate glues have had widespread use among the surgical specialties [2].
Although surgeons have used cyanoacrylates for over 20 years, these adhesives continue to
cause concerns over tissue necrosis and cytotoxicity [3]. Secondly, fibrin sealants have been
developed as tissue adhesives that “mimic” the body’s own natural clotting mechanisms [4].
Because fibrin sealant is derived from blood products, it may be associated with viral-
disease transmission [5]. Thirdly, is the group of products such as gelatin–resorcinol–formol
glue. This adhesive is formed from gelatin, resorcinol, and distilled water in the presence of
formaldehyde, glutaraldehyde, and heat [6]. Toxicity issues and the fact that the glue cannot
be used in a wet environment have dampened enthusiasm for the product [7]. Another glue
in this class is albumin cross-linked with glutaraldehyde, known as Bio-Glue that has been
used to seal dissections in vessels such as the aorta [8]. This has reported problems with
vascular stenosis [9] and inflammation [10]. Fourthly, is a miscellaneous group of light-
activated tissue adhesives and bonding technologies. Hydrogels are a class of synthetic
tissue adhesives that, in general, are applied to the site as liquids and then polymerize into
solids in the presence of light [11]. In preclinical use, this type of sealant has also been
shown to be effective as a hemostatic adjunct to prevent anastomotic bleeding and to seal
other types of closure such as the dura, pancreatic stump, or open wounds. Various dye-
activated protein solders have been investigated as well. These rely on the addition of dyes
to proteins (usually albumin) to absorb light and produce local heating. Dyes that have been
used include indocyanine green [12], methylene blue [13], and fluorescein [14]. There is a
technique, that does neither need a solder nor a glue, known as photochemical tissue
bonding that uses the dye Rose Bengal without exogenous proteins to form direct covalent
bonds between collagen surfaces [15,16].
The ideal light-activated tissue glue for use in the eye will form a strong bond without
producing heat, as delicate tissues such as the cornea do not have a great tolerance for
thermal damage. We previously showed that photodynamically active dyes could be used to
initiate the bonding process and proposed that the reactive oxygen species and radicals
produced by the interaction between the excited dye molecules and oxygen could lead to the
formation of covalent protein cross-links [17]. We reported on chlorin e6 (ce6) as a dye
capable of producing light-activated strong bonds in cadaver scleral wounds when
formulated with albumin as a covalent conjugate [18]. In the present report, we investigate
and compare the in vivo characteristics of photodynamic light-activated tissue glues
(PLATG) formulated with two different dyes; ce6 and Janus Green (JG), another dye
capable of photodynamic reactions. The dye–protein mixture in the glue may also be varied,
as reported in a previous article [18]. Although it is relatively easy to demonstrate tissue
adhesion ex vivo, it is important to study the technology in living animals. Here, we are
concerned not only with effective strength of the glue, but also to verify that the process
does not injure the tissues or cause undue inflammation. We chose to test the glues by
sealing freshly made penetrating corneal incisions in living rats and assessing leaking
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pressure at sacrifice at various times after wounding and by examining eyes for
inflammation by routine histology.
MATERIALS AND METHODS
Preparation of Glues
The preparation of BSA–ce6 was essentially as described [18]. Briefly the N-hydroxy
succinimide (NHS) ester of ce6 (Porphyrin Products, Logan, UT) was prepared by reacting
1.5 equivalents of dicyclohexylcarbodiimide and 1.5 equivalents of NHS with 1 equivalent
of ce6 in dry DMSO for 24 hours). Bovine serum albumin (BSA, Sigma Chemical, St.
Louis, MO) was dissolved in 0.1 M NaHCO3 buffer pH =9.3 at a concentration of 500 mg/
ml (7.4 mM). Equivalents (1.2) of ce6–NHS ester in DMSO were added to the protein
solution and the mixture allowed to stand overnight. The mixture was then dialyzed twice
against 5 L of PBS to remove unconjugated ce6 and DMSO and provided a conjugate with a
1:1 substitution ratio. The conjugate then had one, two, or three times the amount of
unconjugated BSA added and additional PBS to give an overall 50% w/w protein solution.
JG (Aldrich Chemical, Milwaukee, WI) was dissolved in water to give a 2% w/w solution
(25 mM accounting for 65% dye content). The albumin solution was prepared at 50% w/w
in distilled water (7.4 mM) and sufficient JG solution was added to give concentrations of
7.4, 3.7, 2.5, and 1.9 mM (ratios of protein to dye of 1:1, 1:0.5, 1:0.33, 1:0.25). Glues were
characterized by absorption spectroscopy after suitable dilution in 0.1 M NaOH/1% SDS
[18].
Preliminary Testing of Glues
We first conducted ex vivo studies in order to test the appropriate consistency and viscosity
of the glues as well as to compare the adhesive strength of the bonds produced by
illuminating BSA–ce6 conjugate and BSA+JG mixture at different molar ratio of protein to
dye. C57/BL6 mice were purchased from Charles River Laboratories (Wilmington, MA) and
were used in a protocol approved by the Subcommittee on Research Animal Care of
Massachusetts General Hospital. The animals were later euthanized by carbon dioxide
inhalation in accordance with the recommendations of 2000 Report of the AVMA Panel on
euthanasia and then the skin was dissected with a no. 10 blade and instantly placed in
buffered 10% formaldehyde to avoid desiccation. First, skin was cut into thin strips (3 cm
long×0.5 cm wide) and two pieces were held end-to-end by clips so that the gap where the
glue would be applied did not touch any surface. The two pieces of skin were in gentle
contact and the gap between the two pieces varied from 0 to 0.3 mm depending on the minor
irregularities of the skin edge. We applied the glue(approximately50–100μl)between the two
opposed ends of the strips using a 1 ml syringe and a 18-gauge needle. Then the area was
illuminated with the appropriate wavelength laser (665 nm 1 W-diode laser (High Power
Devices, Inc., North Brunswick, NJ) at different fluences(109;87.3;65.5; and32.5J/cm2)with
an irradiance of 181 mW/cm2. Once the two ends had stuck together, the strength of this
union was measured by placing the samples in the tensiometer (Chatillon TCD 200,
Commercial Scale Co., Inc., Agawam, MA). This machine holds the ends of the tissue in
clamps and exerts an increasing force until the tissue separates and reads the force exerted in
Newtons. We repeated the experiments with different ratios of the different glue
preparations.
Rat Model of Penetrating Corneal Wound
The protocol was reviewed and approved by the Schepens Eye Research Institute Animal
Care and Use Committee and was in compliance with NIH and Association for Research in
Vision and Ophthalmology guidelines. Only one eye of each animal was operated upon.
Sprague Dawley (Charles River) rats weighing approximately 350 g were obtained. The rats
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were anesthetized using ketamine (80 mg/kg) and xylazine (12/mg/kg) by injection in the
peritoneal cavity. Immediately prior to surgery, mydriasis was achieved in the experimental
eye by placing two drops of cyclopentolate 1% and phenylephrine 10%. In order to reduce
the flow of aqueous across the wound, timolol 0.5% was also placed on the eye.
Immediately prior to surgery, the topical local anesthetic proparacaine was placed on the
eye. Under a surgical microscope, traction sutures using 6-0 silk were placed through
conjunctiva/Tenon’s capsule at 3:00 and 9:00 o’clock and used to prolapse and secure the
globe. The corneal epithelium was removed using a Grieshaber scarifier blade. A diamond
knife was set to 300 μM and used to make a 6-mm incision in the center of the cornea. The
full-thickness of the incision was ensured by placement of one blade of a Vannas scissors
through the wound to ensure complete perforation for the extent of the wound. For the
control group, the procedure ended here by removing the traction sutures, injecting a sub-
Tenon’s depot of the anti-inflammatory steroid, dexamethasone (0.3 ml), and irrigating the
wound.
For the experimental groups, one of the two formulations of PLATG (BSA+BSA–ce6, and
BSA+JG both at 1:0.33 protein to dye ratio) was applied to the wound using a 1-ml syringe
and a 18-gauge needle. Using the tip of the needle, approximately 50–100 μl of PLATG was
placed between the wound edges, but not injected into the anterior chamber. A 665 nm laser
(BW-Tek Laser Systems, Baltimore, MD) operating at 300 mW and giving a 4-mm diameter
spot size, was applied to the wound in a continuous back and forth
motionforapproximately2minutes. Allowing for the average dwell time of the light to be
approximately 25%on any area of the glue, the total fluence delivered was 71.5 J/cm2 at an
irradianceof600mW/cm2. Any area of the wound found to be leaking aqueous underwent
further glue and laser application as outlined above. The silk sutures were removed, a sub-
Tenon’s depot of the anti-inflammatory steroid, dexamethasone (0.3 ml) placed, and the
wound irrigated.
The eyes of the rats were photographed using a slit-lamp biomicroscope (Model 900, Haag-
Streit AG, Koeniz, Switzerland) and sacrificed at 1, 7, and 14 days following the treatment.
The treated eyes were enucleated with forceps and scissors (to cut muscles and optic nerve)
and randomly divided into two groups for measuring of leaking pressure and
histopathological examination.
Leaking Pressure
In order to measure leaking pressures, an 18-gauge butterfly needle was connected via
plastic tubing to a water bottle. The inner pressure in the bottle was controlled by a hand-
pumped sphygmomanometer. The butterfly needle was inserted in the vitreous cavity
through equatorial sclera, and the sphygmomanometer was increasingly pressurized in ~10-
mmHg increments. Leaking pressure was recorded the moment the wound leaked air or
fluid.
Histopathology
A 6-0 silk suture was placed at the limbus of each enucleated eye to mark the end of the
incision. The eyes were fixed in formalin, cross-sectioned perpendicular to the wound, and
stained using hematoxylin and eosin.
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RESULTS
Glue Formulation
The chemical structures of BSA–ce6 and JG are shown in Figure 1. The spectra of the glues
prepared at a protein:dye ratio of 1:0.33 are shown in Figure 2 illustrating the wavelength of
the red laser used to activate the dyes.
Experiments on Glue Formulation
The effect that the protein:dye ratio had on the strength of the bonds when BSA–ce6 was
mixed with BSA was observed previously [18]. In those experiments the conjugate
(BSA:ce6 =1:1) with added unconjugated BSA (to make BSA:ce6 =4:1) was shown to give
significantly higher breaking strength than conjugate or mixtures with lower BSA:ce6 ratios.
In the present work, we undertook a preliminary series of experiments to determine the
optimum ratio of BSA to JG and sought to confirm our previous finding with BSA–
ce6+BSA. In contrast to the previous study [18] that used cadaver eyes with scleral incisions
sealed using Argon laser light (488 and 514-nm), in the present case we used strips of mouse
skin and 665-nm diode laser light and tested the breaking strength with a tensiometer. The
results are shown in Figure 3. The strips were bonded edge to edge and the surface area of
each edge was approximately 4 mm2 (5-mm long by 0.8-mm thick). The breaking strength
measured of 2.5 N was therefore equal to 62.5 N/cm2.
The BSA–ce6 based glue was most effective at a ratio of 1 protein to 0.33 dye, followed by
the 1:0.25 ratio and the least strong bond (but nevertheless effective) was produced by the
1:1 and 1:0.5 ratios (Fig. 3a). The JG based glue gave overall stronger bonds than the
corresponding ce6 based glues. Again the 1:0.33 ratio gave the strongest bonds followed by
the 1:0.5 with the other ratios slightly less strong (Fig. 3b). In all cases the strength of the
bonds was directly proportional to the delivered fluence as might be expected for a
photochemical process.
Clinical Outcome
The rats showed no acute intraoperative or postoperative complications such as collapse of
the anterior chamber, bleeding/hyphema, etc. After the first day, there were no eyelid
adhesions and all lid movements were normal. There was no excessive tearing. On many
eyes, the glue was still present by the 1 day (Fig. 4A) and traces were occasionally observed
at the 7-day examinations (Fig. 4B), but was always gone by the 14-day exam (Fig. 4C).
There was no conjunctival inflammation or hyperemia by the 7-day point. Figure 4 shows
examples of the slit-lamp photographs of the glued eyes at the 1, 7, and 14 day time points.
There was no significant differences observed between eyes glued with BSA+JG and with
BSA+BSA–ce6.
Leaking Pressure
Information on the relative strengths of the wounds sealed with the PLATG or left untreated
was obtained by using a pressurized system to inflate the enucleated eyes with water until
the wound either burst or leaked. The results are shown in Table 1. In the eyes which were
taken from rats sacrificed 24 hours after wounding we see that those eyes that had wounds
closed with both BSA–ce6 and JG PLATG had leaking pressure significantly higher than
control eyes, and the eyes sealed with JG had significantly higher leaking pressures than
those sealed with BSA–ce6. At 1 week after wounding, the leaking pressures of the PLATG
sealed eyes had fallen to match the pressures of control eyes as the protein glues
biodegraded. At 2 weeks after wounding, the incisions had healed and the leaking pressures
of all the eyes were similar and higher than the capacity of the system to measure.
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Histopathology
Enucleated eyes were fixed in formalin and processed for standard hematoxylin and eosin
histology. Figure 5 illustrates the typical findings. In panel (i) the untreated wound at 1-day
post wounding shows an immature gaping wound with significant peri-inciscional
inflammation, more than 50% neutrophils. There are also some inflammatory cells including
neutrophils present in the anterior chamber. In contrast very few neutrophils are found in the
subepithelial area away from the site of the incision. Panel (iv) shows a JG glue treated
wound at 1 day post-treatment. There is a moderate inflammatory infiltrate present in the
subepithelial area of the cornea with a significantly diminished degree of infiltration in the
mid and deep layers. The inflammation is divided equally between neutrophils and
mononuclear cells. The wound with overlying hardened glue could easily be observed.
Other than this anterior synechiae, there was a mild degree of exudate and very few
inflammatory cells in the anterior chamber. Panel (vii) shows the ce6 glue at 1 day after
treatment. Moderate amounts of glue were present above the corneal epithelium and in the
anterior chamber against the lens capsule. There was recruitment of neutrophils in the
subepithelial area throughout the cornea and intense stroma edema at the sides of the wound.
Overall, there were significantly more neutrophils in the peri-insicional areas and in the
stroma as compared to JG glue. No inflammatory cells were seen in the anterior chamber.
At 1 week after wounding the control wound in panel (ii) shows stromal edema with a
moderate mixed cell infiltrate around the site of incision. There is epithelial bridging and a
moderate amount of inflammation, mostly neutrophils, in the anterior chamber and the
stroma is also heavily infiltrated at the site of the bridging. The epithelium is normal, and in
fact absent in some areas. The posterior surface is covered with macrophages and
neutrophils with a lot of disorganization in the stromal lamellae and a break in Descemet’s
membrane. The 1-week JG glued eye (detail in panel v) shows epithelial healing over the
area of the penetrating wound. A few inflammatory cells, mostly neutrophils with a few
macrophages, were present around the area of the wound. The wound shows significant
maturation, especially anteriorly. There is no ongoing inflammatory stimulus at the wound
for inflammatory cell recruitment and the anterior chamber is devoid of inflammatory cells.
The 1-week ce6 glued wound (panel viii) showed more stromal edema than at 1 day.
Epithelial and anterior stroma bridging were found. Inflammation and neutrophils were seen
in the stroma, mostly in the anterior and mid stroma and a significant neovascularization had
taken place in the corneal healing.
The control wound at 2 weeks (panel iii) shows a mature wound with very significant
corneal neovascularization. Although neovascularization is necessary for wound healing, an
excessive amount can diminish corneal function. There is iris adherent to the posterior
aspect of the wound, a large area without Descemet’s, a few inflammatory cells in the
cornea, and none in the anterior chamber. There is some disorganization and scarring in the
cornea. The JG glued wound at 2 weeks showed a mature wound with fibrous scar tissue
deposition found at the wound site and hyperplasia of the overlying epithelial cells. There
were very few inflammatory cells in the stroma with primarily keratocytes and a few
mononuclear inflammatory cells being found. No neutrophils were observed and the anterior
chamber was quiet. The ce6 wound at 2 weeks (panel ix) showed very few inflammatory
cells, the wound was completely closed, normal on the surface, with excellent epithelial,
stromal, and even endothelial cell layers. The anterior chamber is perfectly quiet. Scar tissue
filled in the majority of the depth of the incision.
The adhesions seen in panels (ii), (iii), and (viii) can be a sign that the wound was “gaping”
at a critical stage during the healing process. This has the effect of forcing the cornea back
against the iris and with the inflammatory process involved in healing allows adhesions to
form.
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DISCUSSION
This study has shown that PLATG is able to effectively and safely seal corneal incisions in
living rats. The data from the leaking pressure measurements and histopathology studies
respectively support the effective strength and the non-toxic nature of the glues. Although
varying amounts of inflammation were present, this was not excessive in the glued wounds
and in some cases was less than in the unglued control wounds. It should be noted that
inflammation is a normal consequence of the healing process. The measurements of bond
strength clearly showed that the corneal wounds sealed with the JG formulation had a
greater adhesive strength than those wounds sealed with ce6 formulation, and both glues
were significantly better than control (untreated) wounds. Furthermore, the glues were
biodegraded by week 1 as expected, and corneal healing was equal in all eyes after 2 weeks.
The leaking pressure measured in control wounds at day 1 was 193 mmHg showing that to
some extent the wounds were self-sealing. The fact that the leaking pressures in the PLATG
treated eyes dropped to match control eyes at the 1 week time point showed that the
beneficial effects of the increased strength of the seal was only temporary. Further work
could involve looking at time points between 1 day and 1 week to determine the time course
of the loss of strength in the glued wounds. However, the lower incidence of adhesions and
neovascular scar formation in the glued eyes did suggest that the glue might reduce the
“gaping” effect of an unsealed wound. It is possible that a wound could be both “gaping”
and self-sealing at the same time. This could happen if the rear aspect of the wound sealed
and this forced the front edges apart to produce a gaping effect. In addition the PLATG
might provide an addition clinical benefit in that the seal would exclude bacteria and
particulate matter from the open wound. It remains to be seen what effect this procedure
would have on vision.
JG, a novel dye not hitherto used for tissue welding applications, was shown to give superior
performance compared to a covalent conjugate of ce6. Despite JG having shown promising
results in our experiments, we conclude that it still needs further study as a potential PLATG
component. This cationic phenazine azo-dye has been used as a photosensitizer in a series of
experiments on micro-irradiation of vitally stained single cells [19,20]. More recently it has
been used in ophthalmology as a vital stain to quantify toxicity to the corneal endothelium
[21]. In addition, due to its mitochondrial localization it has been proposed as an anti-
malarial compound [22]. Nevertheless, it has not to our knowledge been used in any
chromophore-assisted tissue glue or welding application. Studies will need to be conducted
to measure to what extent the dye is absorbed by cells and tissue when topically applied and
to verify its lack of long-term toxicity or ill effects.
The results of the leaking pressure measurements are very similar to those found by us in
previous work [18] where BSA–ce6 based glue was used to seal corneal wounds in
cadaveric human eyes (375-mmHg immediately afterwards), compared to the present study
using wounds in living rat eyes (350-mmHg 1 day after). Our group has previously shown
that a light-activated glue composed of riboflavin-6-phosphate and fibrinogen gave a
somewhat lower strength seal in cadaver eyes (260 mmHg) [17] and this preparation was
used to seal incisions in eyes of living rabbits with satisfactory bonding and non-
inflammatory outcome [23,24]. Fibrinogen, as the exogenous protein, however, is
problematical in that it needs to be isolated from human plasma with the accompanying risk
of virus transmission. Photochemical keratodesmos (PKD) is a technique that employs the
dye Rose Bengal to directly bond collagen surfaces and has also shown good results in terms
of bonding strength (254-mmHg), but once again, those studies were performed in
enucleated eyes [16]. Moreover, in contrast to PLATG, which can also be used to fill
irregular wound gaps, close contact of the wound edges is imperative for PKD to be
successful. The high irradiances used with the argon laser and Rose Bengal [16] increased
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the likelihood of thermal damage to the cornea with values of 2.55 and 3.82 W/cm2 being
reported as problematical.
The present results suggest that good seals can be obtained using PLATG without the
requirement of high irradiance (only 600 mW/cm2), which reduces considerably the risk of
thermal damage to the tissue (no evidence of thermal damage in any of our histopathology
studies). In general photochemical processes depend on fluence and not on irradiance, while
photothermal processes depend on irradiance rather than fluence. The irradiance of 600 mW/
cm2 is exactly the same as the value used for delivering 690-nm light during photodynamic
therapy (PDT) mediated by Visudyne for choroidal neovascularization caused by wet
macular [25]. However, in the case of PDT the light is directly focused onto the retina
through the pupil, while in the present case of PLATG on the corneal surface only a small
portion of light directed to the glue would be expected to reach the retinal surface and thus
the risk of retinal damage caused by this procedure should be small.
Besides the strong bonds that can be obtained with PLATG, there are other relevant
advantages of this technique such as its easy biodegradability (not found in alternative
products such as cyanoacrylates) and its use of a readily available non-infective protein
substrate (not found with Fibrin sealants). Moreover, its non-inflammatory nature and its
apparent lack of cell toxicity suggest that PLATG could also be preferable to cyanocrylates
and gelatin–resorcinol–formol glues.
In a similar fashion to findings in our previous report [18], we found that we needed to
increase the ratio of protein to dye in our ex vivo skin gluing experiments in order to obtain
maximum bond strength. While the explanation for this finding is by no means obvious, we
suggest that effectively decreasing the dye concentration in the mixture while maintaining
the protein concentration at levels necessary to keep its viscosity high, had the effect of
allowing the light to penetrate deeper into what was otherwise an optically dense material.
This deeper penetration of light would make the glue set all the way through and maximize
the bond strength. Still many questions remain to be addressed in this photodynamic tissue
glue procedure. For example, can the oxygen-dependent photochemical processes that
generate covalent cross-links between albumin and collagen be demonstrated? Can PLATG
form tissue seals without harming the surrounding living cells?
Wound sealing using photodynamic processes is an attractive concept as an alternative to
traditional closure techniques such as sutures, staples, and clips especially in those defects in
which the edges cannot be apposed or where the tissues are sensitive to even slight
mechanical deformation as can be induced by sutures, such as ocular tissues. This innovative
technique has been shown to be efficacious, non-thermal, non-toxic, and non-inflammatory;
all highly advantageous features. However, much more work needs to be carried out before
any clinical application could be considered. This should include testing the glues in a non
self-sealing wound model in vitro or in vivo. This may determine how important a strong
but relatively short-lasting bond is in wound closure. It is possible that in the cornea a less
strong bond such as that provided by fibrin glue might perform as well as PLATG. The fact,
however, that such strong bonds can be obtained in the eye encourages further studies on the
application of this technology to other disciplines that encounter delicate tissues or involve
microsurgery such as orthopedic or dermatologic applications.
Acknowledgments
We thank Tayyaba Hasan for support for this project.
Contract grant sponsor: NIH; Contract grant number: R01-CA/AI838801.
Khadem et al. Page 8
Lasers Surg Med. Author manuscript; available in PMC 2011 April 6.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
References
1. Charters A. Wound glue: A comparative study of tissue adhesives. Accid Emerg Nurs. 2000; 8:223–
227. [PubMed: 11760325]
2. Tseng YC, Hyon SH, Ikada Y, Shimizu Y, Tamura K, Hitomi S. In vivo evaluation of 2-
cyanoacrylates as surgical adhesives. J Appl Biomater. 1990; 1:111–119. [PubMed: 10148989]
3. Toriumi DM, Raslan WF, Friedman M, Tardy ME. Histotoxicity of cyanoacrylate tissue adhesives.
A comparative study. Arch Otolaryngol Head Neck Surg. 1990; 116:546–550. [PubMed: 2183824]
4. Sierra DH. Fibrin sealant adhesive systems: A review of their chemistry, material properties, and
clinical applications. J Biomater Appl. 1993; 7:309–352. [PubMed: 8473984]
5. Clark RA. Fibrin glue for wound repair: Facts and fancy. Thromb Haemost. 2003; 90:1003–1006.
[PubMed: 14652630]
6. Albes JM, Krettek C, Hausen B, Rohde R, Haverich A, Borst HG. Biophysical properties of the
gelatin–resorcin–formaldehyde/glutaraldehyde adhesive. Ann Thorac Surg. 1993; 56:910–915.
[PubMed: 8215668]
7. Nomori H, Horio H, Suemasu K. The efficacy and side effects of gelatin–resorcinol formaldehyde–
glutaraldehyde (GRFG) glue for preventing and sealing pulmonary air leakage. Surg Today. 2000;
30:244–248. [PubMed: 10752777]
8. Passage J, Jalali H, Tam RK, Harrocks S, O’Brien MF. BioGlue surgical adhesive—An appraisal of
its indications in cardiac surgery. Ann Thorac Surg. 2002; 74:432–437. [PubMed: 12173825]
9. Economopoulos GC, Dimitrakakis GK, Brountzos E, Kelekis DA. Superior vena cava stenosis: A
delayed BioGlue complication. J Thorac Cardiovasc Surg. 2004; 127:1819–1821. [PubMed:
15173746]
10. Erasmi AW, Sievers HH, Wolschlager C. Inflammatory response after BioGlue application. Ann
Thorac Surg. 2002; 73:1025–1026. [PubMed: 11899165]
11. Sweeney T, Rayan S, Warren H, Rattner D. Intestinal anastomoses detected with a
photopolymerized hydrogel. Surgery. 2002; 131:185–189. [PubMed: 11854697]
12. Zuger BJ, Ott B, Mainil-Varlet P, Schaffner T, Clemence JF, Weber HP, Frenz M. Laser solder
welding of articular cartilage: Tensile strength and chondrocyte viability. Lasers Surg Med. 2001;
28:427–434. [PubMed: 11413554]
13. Birch JF, Mandley DJ, Williams SL, Worrall DR, Trotter PJ, Wilkinson F, Bell PR. Methylene
blue based protein solder for vascular anastomoses: An in vitro burst pressure study. Lasers Surg
Med. 2000; 26:323–329. [PubMed: 10738296]
14. Poppas DP, Mininberg DT, Hyacinthe L, Spencer JR, Schlossberg SM. Patch graft urethroplasty
using dye enhanced laser tissue welding with a human protein solder: A preclinical canine model.
J Urol. 1993; 150:648–650. [PubMed: 8326614]
15. Chan BP, Kochevar IE, Redmond RW. Enhancement of porcine skin graft adherence using a light-
activated process. J Surg Res. 2002; 108:77–84. [PubMed: 12443718]
16. Mulroy L, Kim J, Wu I, Scharper P, Melki SA, Azar DT, Redmond RW, Kochevar IE.
Photochemical keratodesmos for repair of lamellar corneal incisions. Invest Ophthalmol Vis Sci.
2000; 41:3335–3340. [PubMed: 11006222]
17. Khadem J, Truong T, Ernest JT. Photodynamic biologic tissue glue. Cornea. 1994; 13:406–410.
[PubMed: 7995062]
18. Khadem J, Veloso AA Jr, Tolentino F, Hasan T, Hamblin MR. Photodynamic tissue adhesion with
chlorin(e6) protein-conjugates. Invest Ophthalmol Vis Sci. 1999; 40:3132–137. [PubMed:
10586934]
19. Baba K. Selective injury of mitochondria with Janus Green B and ruby laser light—Enzyme
morphological and ultrastructural study. Acta Pathol Jpn. 1970; 20:59–78. [PubMed: 4195425]
20. van Duijn C Jr. Photodynamic effects of vital staining with diazine green (Janus Green) on living
bull spermatozoa. Exp Cell Res. 1961; 25:120–130. [PubMed: 13888292]
21. Dua HS, Benedetto DA, Azuara-Blanco A. Protection of corneal endothelium from irrigation
damage: A comparison of sodium hyaluronate and hydroxypropylmethylcellulose. Eye. 2000;
14(Pt 1):88–92. [PubMed: 10755108]
Khadem et al. Page 9
Lasers Surg Med. Author manuscript; available in PMC 2011 April 6.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
22. Vennerstrom JL, Makler MT, Angerhofer CK, Williams JA. Antimalarial dyes revisited:
Xanthenes, azines, oxazines, and thiazines. Antimicrob Agents Chemother. 1995; 39:2671–2677.
[PubMed: 8593000]
23. Goins KM, Khadem J, Majmudar PA, Ernest JT. Photodynamic biologic tissue glue to enhance
corneal wound healing after radial keratotomy. J Cataract Refract Surg. 1997; 23:1331–1338.
[PubMed: 9423904]
24. Goins KM, Khadem J, Majmudar PA. Relative strength of photodynamic biologic tissue glue in
penetrating keratoplasty in cadaver eyes. J Cataract Refract Surg. 1998; 24:1566–1570. [PubMed:
9850891]
25. Michels S, Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy.
Invest Ophthalmol Vis Sci. 2003; 44:2147–2154. [PubMed: 12714655]
Khadem et al. Page 10
Lasers Surg Med. Author manuscript; available in PMC 2011 April 6.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Chemical structures of the photodynamic light-activated tissue glues (PLATG) preparations:
Janus Green (JG) dye and bovine serum albumin (BSA)–chlorin e6 (ce6) conjugate.
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Fig. 2.
Absorption spectra of the PLATG preparations. Mixtures with protein:dye ratios of 1:0.33
were dissolved in 0.1 M NaOH at a concentration of 5 μM equivalent dye.
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Fig. 3.
Ex vivo strength skin of glued skin strips. Strips of mouse skin were glued with the
designated ratio of protein to dye with the designated fluence and immediately the breaking
strength was measured by tensiometer.
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Fig. 4.
Slit lamp photographs of rat eyes glued with JG formulation at (A) 1-day; (B) 7 days; and
(C) 14 days post wounding. [Figure can be viewed in color online via
www.interscience.wiley.com.]
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Fig. 5.
Histopathology of eyes. Panels (i–iii) are of control unglued eyes, panels (iv–vi) are of JG
glued eyes, and panels (vii–ix) are of ce6 glued eyes. Panels (i), (iv), and (vii) are at 1 day
after wounding; panels (ii), (v), and (vii) are at 7 days after wounding. Panels (iii), (vi), and
(ix) are at 14 days after wounding. In all cases the scale bar is 200 μm. Abbreviations are:
ac, anterior chamber; ad, adhesion; ce, corneal epithelium; cs, corneal stroma; e, edema; g,
glue; i, iris; in, inflammation; mn, mononuclear cells; n, neutrophils; nv, neovascularization;
v, vacuoles. [Figure can be viewed in color online via www.interscience.wiley.com.]
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TABLE 1
Leaking Pressure of Eyes (in mmHg) Removed at Designated Times After Treatment
Control Chlorin e6 (ce6) Janus Green (JG)
1 day 193 ± 6 (n =4) 357 ± 25* (n =4) 430 ± 36**,† (n =4)
1 week 232 ± 47 (n =3) 200 ± 26 (n =3) 220 ± 30 (n =3)
2 weeks >500 (n =3) >500 (n =3) >500 (n =3)
*
P <0.01 versus control.
**
P <0.001 versus control.
†
P <0.05 versus ce6.
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